正文

pvalue和padj

發(fā)布時間：2023-03-13 11:32:53 稿源：創(chuàng)意嶺閱讀： 129 問大家

大家好！今天讓創(chuàng)意嶺的小編來大家介紹下關(guān)于pvalue和padj的問題，以下是小編對此問題的歸納整理，讓我們一起來看看吧。

ChatGPT國內(nèi)免費在線使用，一鍵生成原創(chuàng)文章、方案、文案、工作計劃、工作報告、論文、代碼、作文、做題和對話答疑等等

只需要輸入關(guān)鍵詞，就能返回你想要的內(nèi)容，越精準(zhǔn)，寫出的就越詳細(xì)，有微信小程序端、在線網(wǎng)頁版、PC客戶端

官網(wǎng)：https://ai.de1919.com

本文目錄:

1、借助NMF的力量對單細(xì)胞RNA和單細(xì)胞ATAC進(jìn)行聯(lián)合分析
2、統(tǒng)計學(xué)中的p-value是什么？
3、p value的意義
4、那你能不能通俗地解釋正態(tài)分布里的p-value到底是個什么東西[呲牙]

pvalue和padj

一、借助NMF的力量對單細(xì)胞RNA和單細(xì)胞ATAC進(jìn)行聯(lián)合分析

聯(lián)合分析 scRNA-seq 和 scATAC-seq 的流程類似于整合多個 scRNA-seq 數(shù)據(jù)集的流程，都依賴于聯(lián)合矩陣分解和分位數(shù)歸一化。主要區(qū)別在于： （1）scATAC-seq數(shù)據(jù)需要處理成基因級別的值； (2) 僅對 scRNA-seq 數(shù)據(jù)進(jìn)行基因選擇； (3) 下游分析可以使用基因水平和基因間信息 。

為了聯(lián)合分析 scRNA 和 scATAC-seq 數(shù)據(jù)，首先需要將 scATAC-seq 數(shù)據(jù)（一種全基因組表觀基因組測量）轉(zhuǎn)換為與來自 scRNA-seq 的基因表達(dá)數(shù)據(jù)相當(dāng)?shù)幕蛩接嫈?shù) 。大多數(shù)以前的單細(xì)胞研究都使用了一種受傳統(tǒng)bulk ATAC-seq 分析啟發(fā)的方法：識別染色質(zhì)可及峰，然后將與每個基因重疊的所有峰相加。這種策略也很有吸引力，因為 10X CellRanger pipeline是一種常用的商業(yè)軟件包，可以自動輸出這樣的峰值計數(shù)。然而，分析發(fā)現(xiàn)這種策略不太理想，因為：（1）使用所有細(xì)胞執(zhí)行峰值調(diào)用，這會偏向稀有細(xì)胞群； (2) 基因可及性通常比特定調(diào)控元件更分散，因此可能會被峰值調(diào)用算法遺漏； (3) 峰值之外的讀數(shù)信息被丟棄，進(jìn)一步減少了已經(jīng)稀疏的測量中的數(shù)據(jù)量。發(fā)現(xiàn)最簡單的策略似乎效果很好，而不是求和峰值計數(shù)：計算每個細(xì)胞中每個基因的基因體和啟動子區(qū)域（通常為上游 3 kb）內(nèi)的 ATAC-seq 讀數(shù)的總數(shù)。

必須首先使用 sort 命令行實用程序按染色體、開始和結(jié)束位置對 Fragments.tsv 進(jìn)行排序。 -k 選項讓用戶在某個列上對文件進(jìn)行排序；包括多個 -k 選項允許同時按多列排序。 -k 后面的 n 代表“數(shù)字排序”。這里排序的 .bed 文件順序首先由字典染色體順序定義（使用參數(shù) -k1,1），然后是升序整數(shù)起始坐標(biāo)順序（使用參數(shù) -k2,2n），最后是升序整數(shù)結(jié)束坐標(biāo)順序（使用參數(shù)-k3,3n）。

Important flags of bedmap command are as follows:

We can then use LIGER’s makeFeatureMatrix function to calculate accessibility counts for gene body and promoter individually. This function takes the output from bedmap and efficiently counts the number of fragments overlapping each gene and promoter. We could count the genes and promoters in a single step, but choose to calculate them separately in case it is necessary to look at gene or promoter accessibility individually in downstream analyses.

Next, these two count matrices need to be re-sorted by gene symbol. We then add the matrices together, yielding a single matrix of gene accessibility counts in each cell.

5. Once the gene-level scATAC-seq counts are generated, the read10X function from LIGER can be used to read scRNA-seq count matrices output by CellRanger. You can pass in a directory (or a list of directories) containing raw outputs (for example, “/Sample_1/outs/filtered_feature_bc_matrix”) to the parameter sample.dirs. Next, a vector of names to use for the sample (or samples, corresponding to sample.dirs) should be passed to parameter sample.names as well. LIGER can also use data from any other protocol, as long as it is provided in a genes x cells R matrix format.

6. We can now create a LIGER object with the createLiger function. We also remove unneeded variables to conserve memory.

7. Preprocessing steps are needed before running iNMF. Each dataset is normalized to account for differences in total gene-level counts across cells using the normalize function. Next, highly variable genes from each dataset are identified and combined for use in downstream analysis. Note that by setting the parameter datasets.use to 2, genes will be selected only from the scRNA-seq dataset (the second dataset) by the selectGenes function. We recommend not using the ATAC-seq data for variable gene selection because the statistical properties of the ATAC-seq data are very different from scRNA-seq, violating the assumptions made by the statistical model we developed for selecting genes from RNA data. Finally, the scaleNotCenter function scales normalized datasets without centering by the mean, giving the nonnegative input data required by iNMF.

8. We next perform joint matrix factorization (iNMF) on the normalized and scaled RNA and ATAC data. This step calculates metagenes–sets of co-expressed genes that distinguish cell populations–containing both shared and dataset-specific signals. The cells are then represented in terms of the “expression level” of each metagene, providing a low-dimensional representation that can be used for joint clustering and visualization. To run iNMF on the scaled datasets, we use the optimizeALS function with proper hyperparameter settings.

To run iNMF on the scaled datasets, use optimizeALS function with proper hyperparameters setting:

Important parameters are as follows:

9. Using the metagene factors calculated by iNMF, we then assign each cell to the factor on which it has the highest loading, giving joint clusters that correspond across datasets. We then perform quantile normalization by dataset, factor, and cluster to fully integrate the datasets. To perform this analysis, typing in:

Important parameters of quantile_norm are as follows:

10. The quantile_norm function gives joint clusters that correspond across datasets, which are often completely satisfactory and sufficient for downstream analyses. However, if desired, after quantile normalization, users can additionally run the Louvain algorithm for community detection, which is widely used in single-cell analysis and excels at merging small clusters into broad cell classes. This can be achieved by running the louvainCluster function. Several tuning parameters, including resolution, k, and prune control the number of clusters produced by this function. For this dataset, we use a resolution of 0.2, which yields 16 clusters (see below).

11. In order to visualize the clustering results, the user can use two dimensionality reduction methods supported by LIGER: t-SNE and UMAP. We find that often for datasets containing continuous variation such as cell differentiation, UMAP better preserves global relationships, whereas t-SNE works well for displaying discrete cell types, such as those in the brain. The UMAP algorithm (called by the runUMAP function) scales readily to large datasets. The runTSNE function also includes an option to use FFtSNE, a highly scalable implementation of t-SNE that can efficiently process huge datasets. For the BMMC dataset, we expect to see continuous lineage transitions among the differentiating cells, so we use UMAP to visualize the data in two dimensions:

12. We can then visualize each cell, colored by cluster or dataset.

13. LIGER employs the Wilcoxon rank-sum test to identify marker genes that are differentially expressed in each cell type using the following settings. We provide parameters that allow the user to select which datasets to use (data.use) and whether to compare across clusters or across datasets within each cluster (compare.method). To identify marker genes for each cluster combining scATAC and scRNA profiles, typing in:

Important parameters of runWilcoxon are as follows:

14. The number of marker genes identified by runWilcoxon varies and depends on the datasets used. The function outputs a data frame that the user can then filter to select markers which are statistically and biologically significant. For example, one strategy is to filter the output by taking markers which have padj (Benjamini-Hochberg adjusted p-value) less than 0.05 and logFC (log fold change between observations in group versus out) larger than 3:

You can then re-sort the markers by its padj value in ascending order and choose the top 100 for each cell type. For example, we can subset and re-sort the output for Cluster 1 and take the top 20 markers by typing these commands:

15. We also provide functions to check these markers by visualizing their expression and gene loadings across datasets. You can use the plotGene to visualize the expression or accessibility of a marker gene, which is helpful for visually confirming putative marker genes or investigating the distribution of known markers across the cell sequenced. Such plots can also confirm that divergent datasets are properly aligned.

For instance, we can plot S100A9, which the Wilcoxon test identified as a marker for Cluster 1, and MS4A1, a marker for Cluster 4:

These plots indicate that S100A9 and MS4A1 are indeed specific markers for Cluster 1 and Cluster 4, respectively, with high values in these cell groups and low values elsewhere. Furthermore, we can see that the distributions are strikingly similar between the RNA and ATAC datasets, indicating that LIGER has properly aligned the two data types.

16. A key advantage of using iNMF instead of other dimensionality reduction approaches such as PCA is that the dimensions are individually interpretable. For example, a particular cell type is often captured by a single dimension of the space. Furthermore, iNMF identifies both shared and dataset-specific features along each dimension, giving insight into exactly how corresponding cells across datasets are both similar and different. The function plotGeneLoadings allows visual exploration of such information. It is recommended to call this function into a PDF file due to the large number of plots produced.

Alternatively, the function can return a list of plots. For example, we can visualize the factor loading of Factor 7 typing in:

These plots confirm that the expression and accessibility of these genes show clear differences. CCR6 shows nearly ubiquitous chromatin accessibility but is expressed only in clusters 2 and 4. The accessibility is highest in these clusters, but the ubiquitous accessibility suggests that the expression of CCR6 is somewhat decoupled from its accessibility, likely regulated by other factors. Conversely, NCF1 shows high expression in clusters 1, 3, 4, 9 and 11, despite no clear enrichment in chromatin accessibility within these clusters. This may again indicate decoupling between the expression and chromatin accessibility of NCF1. Another possibility is that the difference is due to technical effects–the gene body of NCF1 is short (~15KB), and short genes are more difficult to capture in scATAC-seq than in scRNA-seq because there are few sites for the ATAC-seq transposon to insert.

17. Single-cell measurements of chromatin accessibility and gene expression provide an unprecedented opportunity to investigate epigenetic regulation of gene expression. Ideally, such investigation would leverage paired ATAC-seq and RNA-seq from the same cells, but such simultaneous measurements are not generally available. However, using LIGER, it is possible to computationally infer “pseudo-multi-omic” profiles by linking scRNA-seq profiles–using the jointly inferred iNMF factors–to the most similar scATAC-seq profiles. After this imputation step, we can perform downstream analyses as if we had true single-cell multi-omic profiles. For example, we can identify putative enhancers by correlating the expression of a gene with the accessibility of neighboring intergenic peaks across the whole set of single cells.

Again, for convenience, we have prepared the pre-processed peak-level count data which is ready to use. The data can be downloaded here .

You can also follow the following tutorial to start from the beginning.

To achieve this, we first need a matrix of accessibility counts within intergenic peaks. The CellRanger pipeline for scATAC-seq outputs such a matrix by default, so we will use this as our starting point. The count matrix, peak genomic coordinates, and source cell barcodes output by CellRanger are stored in a folder named filtered_peak_matrix in the output directory. The user can load these and convert them into a peak-level count matrix by typing these commands:

18. The peak-level count matrix is usually large, containing hundreds of thousands of peaks. We next filter this set of peaks to identify those showing cell-type-specific accessibility. To do this, we perform the Wilcoxon rank-sum test and pick those peaks which are differentially accessible within a specific cluster. Before running the test, however, we need to: (1) subset the peak-level count matrix to include the same cells as the gene-level counts matrix; (2) replace the original gene-level counts matrix in the LIGER object by peak-level counts matrix; and (3) normalize peak counts to sum to 1 within each cell.

Now we can perform the Wilcoxon test:

19. We can now use the results of the Wilcoxon test to retain only peaks showing differential accessibility across our set of joint clusters. Here we kept peaks with Benjamini-Hochberg adjusted p-value < 0.05 and log fold change > 2.

20. Using this set of differentially accessible peaks, we now impute a set of “pseudo-multi-omic” profiles by inferring the intergenic peak accessibility for scRNA-seq profiles based on their nearest neighbors in the joint LIGER space. LIGER provides a function named imputeKNN that performs this task, yielding a set of profiles containing both gene expression and chromatin accessibility measurements for the same single cells:

Important parameters of imputeKNN are as follows:

21. Now that we have both the (imputed) peak-level counts matrix and the (observed) gene expression counts matrix for the same cells, we can evaluate the relationships between pairs of genes and peaks, linking genes to putative regulatory elements. We use a simple strategy to identify such gene-peak links: Calculate correlation between gene expression and peak accessibility of all peaks within 500 KB of a gene, then retain all peaks showing statistically significant correlation with the gene. The linkGenesAndPeaks function performs this analysis:

Important parameters of linkGenesAndPeaks are as follows:

22. The output of this function is a sparse matrix with peak names as rows and gene symbols as columns, with each element indicating the correlation between peak i and gene j (or 0 if the gene and peak are not significantly linked). For example, we can subset the results for marker gene S100A9, which is a marker gene of Cluster 1 identified in the previous section, and rank these peaks by their correlation:

We also provide a function to transform the peaks-gene correlation matrix into an Interact Track supported by UCSC Genome Browser for visualizing the calculated linkage between genes and correlated peaks. To do this, tying in:

Important parameters of makeInteractTrack are as follows:

The output of this function will be a UCSC Interact Track file named ‘Interact_Track.bed’ containing linkage information of the specified genes and correlated peaks stored in given directory. The user can then upload this file as a custom track using this page https://genome.ucsc.edu/cgi-bin/hgCustom and display it in the UCSC Genome browser.

As an example, the three peaks most correlated to S100A9 expression are shown below in the UCSC genome browser. One of the peaks overlaps with the TSS of S100A8, a neighboring gene that is co-expressed with S100A9, while another peak overlaps with the TSS of S100A9 itself. The last peak, chr1:153358896-153359396, does not overlap with a gene body and shows strong H3K27 acetylation across ENCODE cell lines, indicating that this is likely an intergenic regulatory element.

If we plot the accessibility of this peak and the expression of S100A9, we can see that the two are indeed very correlated and show strong enrichment in clusters 1 and 3. Thus, the intergenic peak likely serves as a cell-type-specific regulator of S100A9.

生活很好，有你更好

二、統(tǒng)計學(xué)中的p-value是什么？

P-value基本翻譯：假定值、假設(shè)機率。用SAS、SPSS等專業(yè)統(tǒng)計軟件進(jìn)行

P值的意義

1、P值是一種概率，一種在原假設(shè)為真的前提下出現(xiàn)觀察樣本以及更極端情況的概率。

2、拒絕原假設(shè)的最小顯著性水平。

3、觀察到的(實例的) 顯著性水平。

4、表示對原假設(shè)的支持程度，是用于確定是否應(yīng)該拒絕原假設(shè)的另一種方法。

三、p value的意義

P-value基本翻譯：假定值、假設(shè)機率。用SAS、SPSS等專業(yè)統(tǒng)計軟件進(jìn)行假設(shè)檢驗，在假設(shè)檢驗中常見到P 值方法( P-Value，Probability，Pr)，這是由于它更容易應(yīng)用于計算機軟件中。

在統(tǒng)計學(xué)問題中，我們經(jīng)常會見到P值或者P-value，比如回歸分析中，通過P值來判斷回歸變量的合理性。P-value，是顯著性的值，假設(shè)檢驗是推斷統(tǒng)計中的一項重要內(nèi)容，是用于判斷原始假設(shè)是否正確的重要證據(jù)。如p=0.01，p=0.05。

P在醫(yī)學(xué)統(tǒng)計學(xué)中代表假定值（P-value），假定事件發(fā)生的概率；在血檢驗中代表電解質(zhì)磷元素（Phosphorus）。

P代表脈搏：正常人脈搏在安靜、清醒時為60-100次/分，老年人偏慢，女性稍快，＜3歲的兒童多在100次以上。脈搏受生理，如緊張以后會增快；病理高熱甲亢會增快、藥物，如美托洛爾等會使心率減慢。

P-value就是H0假設(shè)成立的時，我們要驗證的那個結(jié)果所出現(xiàn)的概率。如果P值很小，就說明在Ho成立的前提下，我們要檢驗的那個結(jié)果出現(xiàn)的概率很小，當(dāng)一個事件發(fā)生的概率很小時，我們可以大致認(rèn)為，這件事情不可能發(fā)生。

也就是說，在Ho成立的前提下，我們要檢驗的那個結(jié)果不可能出現(xiàn)，但是現(xiàn)實情況是這個結(jié)果出現(xiàn)了，所以我們有理由相信，Ho是不成立的額，所以我們可以拒絕Ho。

四、那你能不能通俗地解釋正態(tài)分布里的p-value到底是個什么東西[呲牙]

P-value基本翻譯是假定值，假設(shè)機率。

根據(jù)顯著性檢驗方法所得到的P值，一般以P<0.05為顯著，P<0.01為非常顯著，其含義是樣本間的差異由抽樣誤差所致的概率小于0.05或0.01。實際上，P值不能賦予數(shù)據(jù)任何重要性，只能說明某事件發(fā)生的機率。

正態(tài)分布（Normaldistribution），也稱“常態(tài)分布”，又名高斯分布（Gaussiandistribution），最早由棣莫弗（AbrahamdeMoivre）在求二項分布的漸近公式中得到。C.F.高斯在研究測量誤差時從另一個角度導(dǎo)出了它。

以上就是關(guān)于pvalue和padj相關(guān)問題的回答。希望能幫到你，如有更多相關(guān)問題，您也可以聯(lián)系我們的客服進(jìn)行咨詢，客服也會為您講解更多精彩的知識和內(nèi)容。